Carbon-dioxide portography: an expanding role?

Vlachogiannakos, John; Patch, David; Watkinson, A.; Tibballs, Jonathan; Burroughs, AK

doi:10.1016/s0140-6736(00)99020-2

Cited by 15 publications

(10 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This combined procedure is easy to perform in practice. 32 In patients who develop HVPG >10 mm Hg, complications of portal hypertension are known to develop 24 34 and this could be an end point in studies. In patients with normal HVPG, maintaining a normal pressure should be a sign of good prognosis.…”

Section: Resultsmentioning

confidence: 99%

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Burroughs

Groszmann²,

Bosch³

et al. 2002

Gut

115

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Burroughs

Groszmann²,

Bosch³

et al. 2002

Gut

115

View full text Add to dashboard Cite

“…MR angiography has precluded the use of effective, but more invasive techniques like carbon dioxide portography or intraarterial digital subtraction angiography. 103,104 PET CT has been shown to be helpful in discriminating between benign and malignant portal vein obstruction. 105 …”

Section: Computed Tomography and Magnetic Resonance Imagingmentioning

confidence: 99%

Portal Vein Thrombosis

Chawla

Bodh

2015

Journal of Clinical and Experimental Hepatology

150

147

View full text Add to dashboard Cite

Portal vein thrombosis is an important cause of portal hypertension. PVT occurs in association with cirrhosis or as a result of malignant invasion by hepatocellular carcinoma or even in the absence of associated liver disease. With the current research into its genesis, majority now have an underlying prothrombotic state detectable. Endothelial activation and stagnant portal blood flow also contribute to formation of the thrombus. Acute non-cirrhotic PVT, chronic PVT (EHPVO), and portal vein thrombosis in cirrhosis are the three main variants of portal vein thrombosis with varying etiological factors and variability in presentation and management. Procoagulant state should be actively investigated. Anticoagulation is the mainstay of therapy for acute non-cirrhotic PVT, with supporting evidence for its use in cirrhotic population as well. Chronic PVT (EHPVO) on the other hand requires the management of portal hypertension as such and with role for anticoagulation in the setting of underlying prothrombotic state, however data is awaited in those with no underlying prothrombotic states. TIPS and liver transplant may be feasible even in the setting of PVT however proper selection of candidates and type of surgery is warranted. Thrombolysis and thrombectomy have some role. TARE is a new modality for management of HCC with portal vein invasion. ( J CLIN EXP HEPATOL 2015;5:22-40)

show abstract

“…According to our experience, highlighted in these 2 patients, carbon dioxide can be used in real time during a TIPS procedure, providing an effective "road map" for portal vein puncture. 28 There were no complications associated with postprocedure anticoagulation.…”

Section: Discussionmentioning

confidence: 88%

Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt

Liatsos

Vlachogiannakos

Patch

et al. 2001

Liver Transplantation

View full text Add to dashboard Cite

A frequent complication in patients with end-stage liver disease is portal vein thrombosis (PVT). Although PVT is not considered an absolute contraindication to orthotopic liver transplantation (OLT), more complex surgery is required and patients have more postoperative complications and greater mortality rates. We describe 2 patients who experienced complete PVT either while waiting for liver transplantation or during the workup, resulting in acute deterioration of liver function. Recanalization of the portal vein was successfully performed in both patients using transjugular intrahepatic portosystemic stent shunt (TIPS), and patency was maintained by the addition of anticoagulation therapy. They subsequently underwent successful OLTs and remain well. In conclusion, we believe that TIPS placement can be performed safely in patients with recent PVT, ensuring the patency of the portal vein until OLT. (Liver Transpl 2001;7:453-460.)

show abstract

Carbon-dioxide portography: an expanding role?

Cited by 15 publications

References 4 publications

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Portal Vein Thrombosis

Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt

Contact Info

Product

Resources

About